ID
12602
Description
Efficacy and Safety of Levosimendan in Severe Acute Heart Failure in Critical Children; ODM derived from: https://clinicaltrials.gov/show/NCT01301313
Link
https://clinicaltrials.gov/show/NCT01301313
Keywords
Versions (1)
- 12/4/15 12/4/15 -
Uploaded on
December 4, 2015
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Acute Heart Failure NCT01301313
Eligibility Acute Heart Failure NCT01301313
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Informed consent denied
Data type
boolean
Alias
- UMLS CUI [1]
- C0021430
Description
cardiomyopathy
Data type
boolean
Alias
- UMLS CUI [1]
- C0878544
Description
aortic stenosis
Data type
boolean
Alias
- UMLS CUI [1]
- C0003507
Description
allergy
Data type
boolean
Alias
- UMLS CUI [1]
- C0020517
Description
it is not possible to prescribe the study medication because it is contraindicated according to the summary of the product characteristic or according to the criteria of the physician responsible for patient
Data type
boolean
Alias
- UMLS CUI [1]
- C1301624
- UMLS CUI [2]
- C0009488
Description
Pregnancy
Data type
boolean
Alias
- UMLS CUI [1]
- C0549206
Similar models
Eligibility Acute Heart Failure NCT01301313
- StudyEvent: Eligibility
C0264714 (UMLS CUI [2])
C0009488 (UMLS CUI [2])